NAGE MEXC RealStocks
Own real NAGE shares through MEXC's regulated brokerage partner.
Suitable for long-term holding.
- Own the actual shares
- Receive dividends and voting rights
- Buy fractional shares starting at $1
Last updated: 2026-11-18 15:04:40. Prices reflect the latest regular market data. Stock price data is sourced from Massive.
Niagen Bioscience, Inc. (NAGE) operates in the MEDICINAL CHEMICALS & BOTANICAL PRODUCTS sector and is listed on NASDAQ. The stock is currently priced at $2.09, with a market capitalization of $159.19M and a P/E ratio of 15.78. Over the past 52 weeks, its price has ranged from $1.95 to $7.12. This page covers its latest market performance, valuation, price trends and company information.
$159.19M | |
$2.02 | |
$2.09 | |
$2.00 | |
$2.04 | |
28.11K | |
506.20K | |
15.78 | |
$7.12 | |
$1.95 | |
-- | |
2026-09-30 |
Niagen Bioscience, Inc. (NAGE) is currently trading at $2.09 as of 2026-11-18 14:48:10, up 1.96% ($0.04) from the previous close of $2.04
During today's regular trading session, NAGE has traded between $2.00 and $2.09, with a trading volume of 28.11K shares. The current price is near the upper end of today's range.
Over the past seven days, Niagen Bioscience, Inc. (NAGE) moved from $2.28 to $2.09, representing a decline of 8.55% ($0.19).
The stock traded between $1.95 and $2.29 during the period. The latest price is near the middle of the 7-day range, indicating strong downward.
The average daily volume was 582.16 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 2.6%
NAGE is currently trading at $2.09, placing it 2.6% of the way from its 52-week low of $1.95 to its 52-week high of $7.12. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Niagen Bioscience Inc is the leader in NAD+ (nicotinamide adenine dinucleotide) science and healthy-aging research. It is dedicated to advancing healthspan through precision science and innovative NAD+-boosting solutions. It is is clinically proven to increase NAD+ levels efficiently and effectively, and is the key ingredient powering our suite of Niagen brands.
| Industry | MEDICINAL CHEMICALS & BOTANICAL PRODUCTS |
| Employees | 117 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Niagen Bioscience, Inc. (NAGE) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Stock prices and market data on this page, including price changes and market status, are provided by Massive and other third-party news and data platforms. Market data may be delayed and may differ from prices on other platforms or the prices at which trades are executed on MEXC. MEXC does not guarantee the accuracy, completeness, or timeliness of third-party data. MEXC offers trading products related to NAGE, including Stocks, Tokenized Stocks, and Stock Futures.
The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.
Estimate the value between NAGE shares and USD.
NAGE Shares to USD
1.00 NAGE shares = 2.085 USD
Calculations are estimates based on the latest available price and are for reference only.